1. Home
  2. XBIT vs DIT Comparison

XBIT vs DIT Comparison

Compare XBIT & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.88

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

N/A

Current Price

$62.30

Market Cap

64.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
DIT
Founded
2005
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
64.4M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XBIT
DIT
Price
$1.88
$62.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 92.8K
1.5K
Earning Date
11-20-2026
08-05-2026
Dividend Yield
N/A
★ 0.79%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.40
Revenue
N/A
★ $1,392,388,157.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.47
N/A
P/E Ratio
★ N/A
$43.50
Revenue Growth
N/A
★ 5.30
52 Week Low
$1.80
$59.15
52 Week High
$3.44
$118.50

Technical Indicators

Market Signals
Indicator
XBIT
DIT
Relative Strength Index (RSI) 39.12 47.59
Support Level $1.80 $59.58
Resistance Level $2.42 $65.04
Average True Range (ATR) 0.12 2.07
MACD -0.00 0.16
Stochastic Oscillator 27.27 27.50

Price Performance

Historical Comparison
XBIT
DIT

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: